Lipella Pharmaceuticals
VerifiedA biotechnology company that develops products for intravesical therapy.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$2m (Public information from Jun 2024)
Share price
$0.45 LIPO
Pittsburgh Pennsylvania (HQ)
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (73 %) | (29 %) | 144 % | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (6 %) | (717 %) | (1405 %) | (1025 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (6 %) | (719 %) | (1411 %) | (1027 %) | - | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 101 % | 562 % | 1383 % | - | - | - | - |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
* | N/A | $2.0m | Post IPO Equity |
| Total Funding | 000k | ||
Related Content
Recent News about Lipella Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.